Literature DB >> 35237958

Survey of Approaches for Investigation of Atherosclerosis In Vivo.

Dipak P Ramji1, Yee-Hung Chan2, Alaa Alahmadi2, Reem Alotibi2, Nouf Alshehri2.   

Abstract

Although in vitro model systems are useful for investigation of atherosclerosis-associated processes, they represent simplification of complex events that occur in vivo, which involve interactions between many different cell types together with their environment. The use of animal model systems is important for more in-depth insights of the molecular mechanisms underlying atherosclerosis and for identifying potential targets for agents that can prevent plaque formation and even reverse existing disease. This chapter will provide a survey of such animal models and associated techniques that are routinely used for research of atherosclerosis in vivo.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Animal models; Approaches; Atherosclerosis; Cardiovascular disease; Mice

Mesh:

Year:  2022        PMID: 35237958     DOI: 10.1007/978-1-0716-1924-7_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  79 in total

Review 1.  Animal models of atherosclerosis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-01       Impact factor: 8.311

Review 2.  Animal models of atherosclerosis.

Authors:  Besa Emini Veseli; Paola Perrotta; Gregory R A De Meyer; Lynn Roth; Carole Van der Donckt; Wim Martinet; Guido R Y De Meyer
Journal:  Eur J Pharmacol       Date:  2017-05-05       Impact factor: 4.432

3.  IL-33 reduces macrophage foam cell formation.

Authors:  James E McLaren; Daryn R Michael; Rebecca C Salter; Tim G Ashlin; Claudia J Calder; Ashley M Miller; Foo Y Liew; Dipak P Ramji
Journal:  J Immunol       Date:  2010-06-11       Impact factor: 5.422

4.  Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13.

Authors:  Shanshan Gao; Juan Zhou; Na Liu; Lijun Wang; Qiyue Gao; Yan Wu; Qiang Zhao; Peining Liu; Shun Wang; Yan Liu; Ning Guo; Yan Shen; Yue Wu; Zuyi Yuan
Journal:  J Mol Cell Cardiol       Date:  2015-05-02       Impact factor: 5.000

Review 5.  Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy.

Authors:  James E McLaren; Daryn R Michael; Tim G Ashlin; Dipak P Ramji
Journal:  Prog Lipid Res       Date:  2011-05-13       Impact factor: 16.195

Review 6.  The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis.

Authors:  Melanie L Buckley; Dipak P Ramji
Journal:  Biochim Biophys Acta       Date:  2015-04-15

Review 7.  A perspective on targeting inflammation and cytokine actions in atherosclerosis.

Authors:  Yee-Hung Chan; Dipak P Ramji
Journal:  Future Med Chem       Date:  2020-03-16       Impact factor: 3.808

8.  TL1A inhibits atherosclerosis in apoE-deficient mice by regulating the phenotype of vascular smooth muscle cells.

Authors:  Dan Zhao; Jiaqi Li; Chao Xue; Ke Feng; Lipei Liu; Peng Zeng; Xiaolin Wang; Yuanli Chen; Luyuan Li; Zhisong Zhang; Yajun Duan; Jihong Han; Xiaoxiao Yang
Journal:  J Biol Chem       Date:  2020-09-22       Impact factor: 5.157

Review 9.  In vitro models for assessing the potential cardiovascular disease risk associated with cigarette smoking.

Authors:  Ian M Fearon; Marianna D Gaça; Brian K Nordskog
Journal:  Toxicol In Vitro       Date:  2012-08-23       Impact factor: 3.500

Review 10.  Nutraceutical therapies for atherosclerosis.

Authors:  Joe W E Moss; Dipak P Ramji
Journal:  Nat Rev Cardiol       Date:  2016-07-07       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.